UnitedHealth Group Incorporated $UNH Stock Position Lowered by Oregon Public Employees Retirement Fund

Oregon Public Employees Retirement Fund reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.2% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 110,385 shares of the healthcare conglomerate’s stock after selling 1,316 shares during the period. Oregon Public Employees Retirement Fund’s holdings in UnitedHealth Group were worth $40,520,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of UNH. First Nebraska Trust Co acquired a new position in UnitedHealth Group during the third quarter worth $1,497,000. Factory Mutual Insurance Co. grew its holdings in UnitedHealth Group by 4.4% in the 3rd quarter. Factory Mutual Insurance Co. now owns 273,616 shares of the healthcare conglomerate’s stock valued at $100,439,000 after buying an additional 11,466 shares in the last quarter. Aware Super Pty Ltd as trustee of Aware Super increased its stake in shares of UnitedHealth Group by 30.4% in the 3rd quarter. Aware Super Pty Ltd as trustee of Aware Super now owns 80,103 shares of the healthcare conglomerate’s stock worth $29,404,000 after acquiring an additional 18,682 shares during the last quarter. Gerber Kawasaki Wealth & Investment Management raised its holdings in shares of UnitedHealth Group by 44.9% during the 3rd quarter. Gerber Kawasaki Wealth & Investment Management now owns 1,366 shares of the healthcare conglomerate’s stock worth $502,000 after acquiring an additional 423 shares during the period. Finally, Torren Management LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $46,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

NYSE:UNH opened at $403.10 on Wednesday. UnitedHealth Group Incorporated has a 52 week low of $255.96 and a 52 week high of $461.62. The stock’s fifty day moving average is $390.47 and its two-hundred day moving average is $363.08. The company has a market capitalization of $361.81 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.45 and a beta of 0.51. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The business had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company’s revenue was down .4% compared to the same quarter last year. During the same period in the prior year, the business posted $2.59 EPS. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio is presently 53.00%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. KeyCorp reissued an “overweight” rating on shares of UnitedHealth Group in a report on Wednesday, October 14th. Erste Group Bank downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, August 27th. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $526.00 to $487.00 and set an “overweight” rating on the stock in a report on Tuesday, October 27th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $529.00 to $531.00 and gave the company an “overweight” rating in a research note on Tuesday, October 27th. Finally, Mizuho raised their price target on shares of UnitedHealth Group from $493.00 to $500.00 and gave the stock an “outperform” rating in a report on Thursday, October 22nd. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Earnings and outlook are key tailwinds. UnitedHealth’s quarterly EPS and revenue beat analysts’ estimates, and the company raised its 2026 profit outlook. Those results helped drive an approximately 11% share gain over the month through October 30. UnitedHealth Just Gained 11% in a Month: Take Profits, or Buy More?
• Positive Sentiment: Buying and value-oriented endorsements provide support. ETFs recorded net purchases of UnitedHealth shares, including $35 million in buying on October 29. BetterInvesting Magazine also named UNH its “Undervalued Stock,” though such selections are not a guarantee of future performance. UnitedHealth Group Draws ETF Buying BetterInvesting Magazine Update
• Neutral Sentiment: Optum Insight’s AI investment is a longer-term opportunity with execution risk. UnitedHealth is expanding AI tools to improve efficiency and claims processing, but rising costs mean the spending still needs to translate into profit growth. Will UNH’s Optum Insight Spending Translate Into Profit Growth?
• Negative Sentiment: Political scrutiny could weigh on sentiment. Senator Elizabeth Warren criticized the Trump administration’s approval of UnitedHealth’s $3.3 billion Amedisys acquisition, arguing the deal increases the company’s power over costs and patient care. The comments renew attention to potential regulatory and political risks. Elizabeth Warren Criticizes UnitedHealth’s Amedisys Deal

Insiders Place Their Bets

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.